SALT POINT STRATEGIES

Lobbying for VERTEX PHARMACEUTICALS · Biopharmaceutical company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $40,000.00 income · posted Jan 18, 2026

Lobbying activity 1

Pharmacy

Non-opioid pain relief and drug pipeline issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem